Murex Biotech Limited Company Profile

00:05 EST 2nd March 2015 | BioPortfolio

Murex Biotech Ltd is part of the diagnostics division and is one of four Abbott sites within the UK. The company has steadily expanded to comprise a total UK workforce of over 2500 employees. At Murex, we are dedicated to the development and manufacture of products for the:

  • detection
  • monitoring
  • screening of infectious diseases and other medical conditions.
Murex is based at Dartford, Kent, and its principle focus is a range of enzyme immunoassay products for use by blood transfusion services throughout the world to screen for infectious agents such as hepatitis and HIV. In addition, we have a growing biotechnology group who manufacture recombinant proteins and monoclonal antibodies for use in Abbott products.

Location

Central Road
Dartford
DA1 5LR
United Kingdom

Contact

Phone: 00 44 1322 277711


News Articles [758 Associated News Articles listed on BioPortfolio]

BB Biotech: Biotech-Sektor baut seine Outperformance aus

Küsnacht - Der Nasdaq Biotech Index legte im 4. Quartal weitere 11.2% in USD zu, woraus für das Jahr 2014 eine solide Gesamtrendite von 34.4% in USD resultiert. Das Portfolio von BB Biotech überze....

BB BIOTECH AG: Biotech trotzt Makroumfeld - starke Quartalszahlen für BB Biotech

BB BIOTECH AG / Biotech trotzt Makroumfeld - starke Quartalszahlen für BB Biotech . Verarbeitet und übermittelt durch NASDAQ OMX Corporate Solutions. Für den Inhalt der Mitteilung ist der Emittent ...

BB Biotech schlägt Referenzindex - Ausschüttung wird deutlich erhöht

Schaffhausen (awp) - Die Beteiligungsgesellschaft BB Biotech hat einmal mehr vom Aufwärtstrend des Biotech-Sektors profitiert. Im Geschäftsjahr 2014 resultierte für die BB-Biotech-Aktie eine Kursst...

BB BIOTECH AG: BB Biotech: SNB decision does not alter the good fundamentals of the biotech sector

BB BIOTECH AG / BB Biotech: SNB decision does not alter the good fundamentals of the biotech sector . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible f...

BB BIOTECH AG: BB Biotech: The biotech sector extends its outperformance - new technologies an important driver

BB BIOTECH AG / BB Biotech: The biotech sector extends its outperformance - new technologies an important driver . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely ...

GlobeNewswire/Biotech trotzt Makroumfeld - starke Quartalszahlen für BB Biotech

BB BIOTECH AG / Biotech trotzt Makroumfeld - starke Quartalszahlen für BB Biotech . Verarbeitet und übermittelt durch NASDAQ OMX Corporate Solutions. Für den Inhalt der Mitteilung ist der Emittent....

BB BIOTECH AG: BB Biotech neu im Stoxx Europe 600

BB BIOTECH AG / BB Biotech neu im Stoxx Europe 600 . Verarbeitet und übermittelt durch NASDAQ OMX Corporate Solutions. Für den Inhalt der Mitteilung ist der Emittent verantwortlich. Source: Globene....

BB BIOTECH AG: Biotech bucks macro uncertainties - strong quarterly results for BB Biotech

BB BIOTECH AG / Biotech bucks macro uncertainties - strong quarterly results for BB Biotech . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the c...

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition

The objective of the study is to compare the bioavailability and characterise the pharmacokinetic profile of Mycophenolate mofetil 250 mg capsules Panacea Biotech Ltd, India and Cellcept®...

Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial

This is a randomized, controlled trial in liver transplantation in which conventional immunosuppressive treatment will be compared with a therapeutic strategy consisting in pre-transplant ...

Companies [838 Associated Companies listed on BioPortfolio]

Murex Biotech Limited

Murex Biotech Ltd is part of the diagnostics division and is one of four Abbott sites within the UK. The company has steadily expanded to comprise a total UK workforce of over 2500 employees. At Murex...

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

Nascent Biotech, Inc.

Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of various cancers. Its products are not c...

More Information about "Murex Biotech Limited" on BioPortfolio

We have published hundreds of Murex Biotech Limited news stories on BioPortfolio along with dozens of Murex Biotech Limited Clinical Trials and PubMed Articles about Murex Biotech Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Murex Biotech Limited Companies in our database. You can also find out about relevant Murex Biotech Limited Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topics

Biotechnology - Biotech
Latest News Clinical Trials Research Drugs Reports Corporate
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record